Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1. (Q49937107)
Jump to navigation
Jump to search
scientific article published on 16 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1. |
scientific article published on 16 February 2018 |
Statements
1 reference
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1. (English)
1 reference
Joop van Gerven
1 reference
Milton Bonelli
1 reference
16 February 2018
1 reference
1 reference